FDA Inspection 1202011 — FDC Limited

FDC Limited — FEI 3003204330

The FDA completed an inspection of FDC Limited on Feb 12, 2023 in Aurangabad, Maharashtra State. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Feb 12, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Aurangabad, Maharashtra State (India)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.